Searched for
DACLATASVIR
Prices of drugs going off patent to be slashed to 50%In case of Fixed dose combinations (FDC) where one component is going off patent the ceiling price will be revised by reducing the present ...- Anti-diabetes drugs and patented antivirals to get cheaper, NLEM notifiedFor the first time, patented drugs like anti-TB bedaquiline and delamanid, anti-HIV Dolutegravir and anti-hepatitis C daclatasvir are also ...
- Getting patented meds on NLEM list an uphill battle says committee memberAs many as 34 new drugs were added and 26 dropped from an updated list of essential medicines.For the first time patented drugs like anti-T...
- Diabetes, patented TB, HIV drugs enter essential listPopular anti-diabetes drug teneligliptin, insulin glargine injection, Common antibiotics like meropenem, Cefuroxime have been included in t...
- Mylan set to use hepatitis C combo drugs in COVID-19 phase-2 trialsThe SEC on Covid-19 permitted the company to conduct phase-II trials with caveats such as that the participants should not be more than 65 ...
- Natco Pharma launches Hepatitis C drug in IndiaNatco Pharma launched fixed dose combination of Sofosbuvir-Daclatasvir tablets for the treatment of Hepatitis C under the brand name Hepcin...
- Johnson & Johnson arm halts R&D on Hepatitis C drugInstead, the company will focus on a cure for chronic hepatitis B, an inflammation of the liver caused by a different virus.
- Laurus Labs IPO subscribed 28 per cent on Day 1; 10 things you must knowThe issue received bids for 62,09,420 shares as against 2,19,11,308 on offer, data available with the stock exchanges till 5 pm showed.
- Cadila Healthcare jumps 5% as drugmaker inks pact for Hepatitis C tabletsThe agreement sub-licenses Zydus to produce and sell daclatasvir in 112 low and middle income countries, it added.
- Zydus Cadila inks pact with Medicines Patent Pool for Hepatitis C drugBetween 130 and 150 million people worldwide are estimated to have HCV. The vast majority lives in low and middle income countries, it adde...
- The pill that costs $9,000 in US sells for $70 in IndiaAnd that's just one leukaemia drug. India's generic industry has been producing many such life-saving medicines at a fraction of the global...
- The pill that costs $9,000 in US sells for $70 in IndiaTypically, the price of many expensive patented drugs in European countries like France, Spain or the UK is half of what these cost in the ...
- Natco Pharma signs agreement for manufacturing, sale of hepatitis C drugDaclatasvir, discovered and developed by Bristol-Myer Squibb, is the first-in-class NS5A inhibitor used in combination with Sofosbuvir to t...
- Cipla, Emcure, Hetero and Natco Pharma join patent pool for new Hepatitis C drug DaclatavirThere might be more companies who might join the patent pool for the drug. Daclatasvir is known to cure multiple genotypes of the Hep C vir...
- Desi generics firms pave way for cheaper hepatitis C drugIf scaling up of HIV treatment globally was made possible by Indian generics companies, it looks like they are set to repeat this feat with...
- Hetero receives drug controller approval for generic DaclatasvirDaclatasvir in combination with Sofosbuvir is indicated for the treatment of Hepatitis C genotype 3 infections, which is highly prevalent i...
- Natco Pharma gets DCGI nod to sell hepatitis C treatment drugNatco Pharma has got approval from the Drugs Controller General of India (DCGI) to sell generic version of Daclatasvir, which is used for t...
- Hepatitis C cure may cost as low as Rs 67,000India is now one of the few countries where generics are available for interferon-free treatment of Hepatitis C.
- WHO adds 36 new drugs to list of essential medicinesThe move opens the way to improve access to innovative medicines that show clear clinical benefits and could have enormous public health im...
- New drug combo cures toughest cases of hepatitis CResults were similar in study participants infected with genotypes 2 or 3, strains which are less common in the US.
Load More
